| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.79 M USD | -23784 USD | -3.25 M USD | -5.55 M USD | -4.81 M USD | -4.03 M USD | -2.17 M USD | 277142 USD | -139862 USD | 409245 USD | -1.20 M USD | -1.69 M USD |
| Depreciation & Amortization | 3.95 M USD | 4.92 M USD | 3.68 M USD | 2.37 M USD | 596975 USD | 291370 USD | 119951 USD | 83890 USD | 80648 USD | 60883 USD | 60031 USD | 56446 USD |
| Stock-Based Compensation | 5.15 M USD | 4.44 M USD | 3.44 M USD | 2.70 M USD | 2.67 M USD | 1.40 M USD | 0 USD | — | — | — | — | — |
| Capital Expenditures | 4.63 M USD | 205848 USD | 265246 USD | 147015 USD | 171867 USD | 544374 USD | 182825 USD | 8482 USD | 43895 USD | 3029 USD | 5334 USD | 8072 USD |
| Cash Flow from Investing | -14.97 M USD | -6.61 M USD | -10.21 M USD | -3.51 M USD | -5.28 M USD | -2.74 M USD | -1.20 M USD | -8482 USD | -85875 USD | -3029 USD | -5334 USD | -8447 USD |
| Cash Flow from Financing | 8.89 M USD | 17.37 M USD | 9.64 M USD | -627346 USD | 28.30 M USD | 622330 USD | 9.80 M USD | 0 USD | -144554 USD | 244927 USD | 867120 USD | 2.17 M USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 2.16 M USD | -229632 USD | -3.51 M USD | -5.70 M USD | -4.99 M USD | -4.58 M USD | -2.35 M USD | 268660 USD | -183757 USD | 406216 USD | -1.21 M USD | -1.69 M USD |
Sanara MedTech Inc. is a medical technology company specializing in developing and commercializing advanced wound care products and technologies. The company's primary focus is on enhancing patient outcomes through innovative solutions that address the complex needs of wound management and skin care. Sanara MedTech offers a comprehensive suite of products, including antimicrobial wound dressings, collagen-based products, and surgical site management solutions, which are designed to improve healing and reduce infection risks in chronic and acute wounds. Operating primarily in the healthcare sector, Sanara MedTech collaborates with healthcare providers, hospitals, and outpatient facilities, providing them with cutting-edge technologies that support efficient patient care. The company's commitment to research and development ensures that it remains at the forefront of innovation in the medical field, addressing some of the significant challenges faced by clinicians today. Sanara MedTech's contributions to the wound care industry underscore its vital role in the market, as it not only aids in advancing medical practices but also promotes improved quality of life for patients worldwide. This has positioned the company as a key player in the healthcare landscape, catering to the increasing demand for effective wound care solutions.